• STAT6 mutations enriched at diffuse large B-cell lymphoma relapse reshape the tumor microenvironment 

      Benoit, Alexandre; Abraham, Madelyn; Li, Sheena; Kim, John; Estrada Tejedor, Roger; Bakadlag, Rowa; Subramaniam, Nivetha; Makhani, Kiran; Guilbert, Cynthia (International Journal of Hematology. 2024;119:275–290, 2024-01-29)
      Diffuse large B-cell lymphoma (DLBCL) relapses in approximately 40% of patients following frontline therapy. We reported that STAT6D419 mutations are enriched in relapsed/refractory DLBCL (rrDLBCL) ...